Skip to main content

Table 3 Antimicrobial susceptibility profiles of the 19 Acinetobacter ursingii isolates

From: A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of Acinetobacter ursingii

  No. of A. ursingii isolates     
  S I R I + R MIC range MIC50 MIC90
Ampicillin-Sulbactam 15 3 1 21.1 % ≤2–16 ≤2 16
Ceftazidime 0 3 16 100.0 % 16– ≥ 64 ≥64 ≥64
Ceftriaxone 0 10 9 100.0 % 16– ≥ 64 32 ≥64
Cefepime 11 0 8 42.1 % 4–32 8 32
Imipenem 19 0 0 0.0 % ≤0.25 ≤0.25 ≤0.25
Amikacin 17 0 2 10.5 % ≤2– ≥ 64 ≤2 ≤2
Gentamicin 16 1 2 15.8 % ≤1– ≥ 16 ≤1 8
Ciprofloxacin 10 7 2 47.4 % ≤0.25– ≥ 4 1 2
Levofloxacin 19 0 0 0.0 % ≤0.12–1 0.5 1
Colistin 16 0 3 15.8 % ≤0.5–4 0.5 4
  1. S susceptible, I intermediate susceptible, R resistant
  2. Minimal inhibitory concentrations (MICs) are given in milligrams per liter (mg/L)